Roxadustat, a HIF-PHD inhibitor with exploitable potential on diabetes-related complications
Diabetes mellitus (DM) is a group of metabolic diseases caused by absolute or relative deficiency of insulin secretion and characterized by chronic hyperglycemia. Its complications affect almost every tissue of the body, usually leading to blindness, renal failure, amputation, etc. and in the final...
Saved in:
Main Authors: | Tingting Fang (Author), Congcong Ma (Author), Zhanming Zhang (Author), Luning Sun (Author), Ningning Zheng (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Roxadustat: Not just for anemia
by: Xiaoyu Zhu, et al.
Published: (2022) -
Effects of post-renal anemia treatment with the HIF-PHD inhibitor molidustat on adenine-induced renal anemia and kidney disease in mice
by: Lei Li, et al.
Published: (2020) -
Exploring the natural products chemical space through a molecular search to discover potential inhibitors that target the hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD)
by: Abrar Mohammad Sayaf, et al.
Published: (2023) -
Roxadustat for Patients with Posttransplant Anemia: A Narrative Review
by: Xiaoxiao Tang, et al.
Published: (2023) -
Roxadustat on Renal Anemia with Macroinflammation: A Retrospective Cohort Study
by: Yan Tu, et al.
Published: (2024)